Covalent docking using autodock: Two-point attractor and flexible side chain methods

Protein Science

Volumn 25, Issue 1, 2016, Pages 295-301

  Bianco, Giulia ^a   Forli, Stefano ^b   Goodsell, David S ^b   Olson, Arthur J ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

computational docking; computer aided drug design; covalent inhibitors; ligand protein interactions

Indexed keywords

INDOLE; LIGAND; THIOPHENE; PROTEIN;

ARTICLE; AUTOMATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; COVALENT BOND; CRYSTALLOGRAPHY; FLEXIBLE SIDE CHAIN METHOD; LIGAND BINDING; MEASUREMENT ACCURACY; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN INTERACTION; RELIABILITY; STRUCTURE ANALYSIS; TWO POINT ATTRACTOR METHOD; CHEMISTRY;

AUTOMATION; LIGANDS; MOLECULAR DOCKING SIMULATION; PROTEINS;

EID: 84959230770     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2733     Document Type: Article

References (21)

1. Johnson DS, Weerapana E, Cravatt BF, (2010) Strategies for discovering and derisking covalent, irreversible enzyme inhibitors. Future Med Chem 2: 949-964.
2. Singh J, Petter RC, Baillie TA, Whitty A, (2011) The resurgence of covalent drugs. Nat Rev Drug Discov 10: 307-317.
3. Mah R, Thomas JR, Shafer CM, (2014) Drug discovery considerations in the development of covalent inhibitors. Bioorg Med Chem Lett 24: 33-39.
4. Ouyang X, Zhou S, Su CTT, Ge Z, Li R, Kwoh CK, (2013) CovalentDock: automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints. J Comput Chem 34: 326-336.
5. Zhu K, Borrelli K, Greenwood JR, Day T, Abel R, Farid RS, Harder E, (2014) Docking covalent inhibitors: a parameter free approach to pose prediction and scoring. J Chem Inf Model 54: 1932-1940.
6. London N, Miller RM, Krishnan S, Uchida K, Irwin JJ, Eidam O, Gibold L, Cimermancic P, Bonnet R, Shoichet BK, Taunton J, (2014) Covalent docking of large libraries for the discovery of chemical probes. Nat Chem Biol 10: 1066-1072.
7. Scholz C, Knorr S, Hamacher K, Schmidt B, (2015) DOCKTITE-A highly versatile step-by-step workflow for covalent docking and virtual screening in the molecular operating environment. J Chem Inf Model 55: 398-406.
8. Moitessier N, Englebienne P, Lee D, Lawandi J, Corbeil CR, (2008) Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. British J Pharmacol 153: S7-S26.
9. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD, (2003) Improved protein-ligand docking using GOLD. Proteins 52: 609-623.
10. Kramer B, Rarey M, Lengauer T, (1999) Evaluation of the FlexX incremental construction algorithm for protein-ligand docking. Proteins 37: 228-241.
11. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ, (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791.
12. Österberg F, Morris GM, Sanner MF, Olson AJ, Goodsell DS, (2002) Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins: Structure, Function, and Bioinformatics 46: 34-40.
13. Forli S, Botta M, (2007) Lennard-Jones potential and dummy atom settings to overcome the AUTODOCK limitation in treating flexible ring systems. J Chem Inf Model 47: 1481-1492.
14. Santos-Martins D, Forli S, Ramos MJ, Olson AJ, (2014) AutoDock4(Zn): an improved AutoDock force field for small-molecule docking to zinc metalloproteins. J Chem Inf Model 54: 2371-2379.
15. Forli S, Olson AJ, (2012) A force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking. J Med Chem 55: 623-638.
16. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ, (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 19: 1639-1662.
17. Silvaggi NR, Josephine HR, Kuzin AP, Nagarajan R, Pratt RF, Kelly JA, (2005) Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a «perfect penicillin». J Mol Biol 345: 521-533.
18. Powers JP, Piper DE, Li Y, Mayorga V, Anzola J, Chen JM, Jaen JC, Lee G, Liu J, Peterson G, Tonn GR, Yu Q, Walker NPC, Wang Z, (2006) SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. J Med Chem 49: 1034-1046.
19. Rastelli G, Rosenfeld R, Reid R, Santi DV, (2008) Molecular modeling and crystal structure of ERK2-hypothemycin complexes. J Struct Biol 164: 18-23.
20. Kluter S, Simard JR, Rode HB, Grutter C, Pawar V, Raaijmakers HCA, Barf TA, Rabiller M, van Otterlo WAL, Rauh D, (2010) Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance. Chembiochem 11: 2557-2566.
21. Ontoria JM, Di Marco S, Conte I, Di Francesco ME, Gardelli C, Koch U, Matassa VG, Poma M, Steinkuhler C, Volpari C, Harper S, (2004) The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease. J Med Chem 47: 6443-6446.